Since 2018

Investing in Healthcare Innovation

About Us

About Cairo Capital

We provide capital and strategic partnership to AI and technology-driven healthcare companies that have the potential for exceptional returns and meaningful impact.

We invest in businesses leveraging artificial intelligence, advanced analytics, and innovative technologies to improve patient outcomes, enhance care delivery, and solve critical challenges in the healthcare system. Our focus spans companies at the forefront of diagnostics, digital health, therapeutic innovation, healthcare analytics, and care delivery platforms.

We are distinct in our long-term investment approach, our ability to hold investments without fund lifecycle pressures, our willingness to customize solutions to founder needs, and the excellence with which we execute through disciplined strategic, operational, and financial partnership. We invest to advance human health and flourishing through technology innovation.

Investment Focus

Our Strategies

We invest in AI and technology-enabled businesses transforming healthcare

AI-Powered Diagnostics

Partnering with companies developing advanced imaging, predictive analytics, and clinical decision support tools that enhance diagnostic accuracy and speed.

Learn More

Digital Health Platforms

Supporting innovations in telemedicine, remote patient monitoring, care coordination, and patient engagement technologies that expand access and improve outcomes.

Learn More

Healthcare Analytics

Investing in population health management, operational efficiency solutions, and outcome optimization platforms that drive data-informed healthcare delivery.

Learn More

Therapeutic Innovation

Backing companies advancing drug discovery, precision medicine, and treatment optimization through AI and computational approaches.

Learn More

Care Delivery Technology

Enabling next-generation workflow automation, provider enablement tools, and healthcare system infrastructure that enhances efficiency and quality of care.

Learn More

Ethics & Responsible Innovation

We invest in companies committed to ethical AI development and responsible innovation. Our partners prioritize patient privacy, algorithmic transparency, equitable access, and beneficial outcomes.

Learn More
Our Philosophy

Our Approach

How we partner with exceptional teams to build enduring businesses
01

Patient Capital for Long-Term Growth

We invest with a long-term horizon, free from traditional fund pressures and forced exit timelines. This allows us to partner with companies through multiple growth stages and support founders in building enduring businesses.

02

Customized Investment Structures

Every company and founder has unique needs. We structure our investments to align with your growth strategy, whether leading rounds, co-investing with aligned partners, or providing flexible capital solutions.

03

Strategic Partnership Beyond Capital

We provide operational guidance, facilitate introductions to customers and industry leaders, support team building and hiring, and leverage our network to accelerate company growth. Our goal is to be a trusted partner in your journey.

04

Values-Driven Investing

We pursue both exceptional financial returns and meaningful impact on human health and wellbeing. We partner with teams who share our commitment to advancing healthcare through innovation and excellence.

Get in Touch

Contact Us

For investment inquiries and partnership opportunities

Office Location

Cairo Capital
525 Metro Place North
Suite 300
Dublin, Ohio 43017

Email Address

contactus@cairocap.us


AI-Powered Diagnostics

We partner with companies developing breakthrough diagnostic solutions that leverage artificial intelligence and advanced analytics to enhance accuracy, speed, and accessibility.

Our focus includes:

  • Medical imaging platforms using computer vision for disease detection
  • Clinical decision support systems that assist healthcare providers in real-time
  • Predictive analytics tools for early disease identification and risk stratification

We seek companies with strong clinical validation, proprietary technology, clear regulatory pathways, and teams that combine clinical and technical expertise to deliver measurable improvements in patient outcomes.

Contact Us to Discuss Your Company →

Digital Health Platforms

We invest in platforms that expand access to care and improve patient outcomes through telemedicine, remote monitoring, and care coordination technologies.

Our areas of interest include:

  • Virtual care delivery systems that integrate seamlessly with existing healthcare workflows
  • Connected devices and platforms for chronic disease management
  • Care coordination tools that enhance multi-disciplinary collaboration
  • Patient engagement solutions that drive behavior change and adherence

We look for companies with demonstrated clinical impact, strong user adoption metrics, clear reimbursement pathways, and HIPAA-compliant infrastructure that scales efficiently across diverse healthcare settings.

Contact Us to Discuss Your Company →

Healthcare Analytics

We support companies transforming healthcare data into actionable insights that drive better clinical, operational, and financial decisions.

Our investment focus includes:

  • Population health management platforms for risk stratification and care gap identification
  • Operational analytics that optimize revenue cycle and resource utilization
  • Clinical analytics for treatment pathway optimization and outcomes measurement
  • Financial analytics for cost prediction and performance tracking

We seek companies with access to high-quality datasets, validated predictive models, clear ROI propositions, and the ability to integrate seamlessly into existing healthcare workflows while delivering measurable business impact.

Contact Us to Discuss Your Company →

Therapeutic Innovation

We back companies using artificial intelligence and computational approaches to accelerate drug discovery, enable precision medicine, and optimize treatment delivery.

Our areas of focus include:

  • AI-powered platforms for target identification and molecule design
  • Precision medicine tools for genomic analysis and patient stratification
  • Clinical trial innovation that improves recruitment and design efficiency
  • Treatment optimization systems that personalize therapy selection and dosing

We invest in companies with strong scientific validation, clear regulatory strategies, significant commercial potential in large markets, and experienced teams capable of navigating the complex drug development landscape while maintaining capital efficiency.

Contact Us to Discuss Your Company →

Care Delivery Technology

We invest in the foundational systems and tools that enable healthcare organizations to deliver care more efficiently and effectively.

Our focus includes:

  • Workflow automation for administrative and clinical tasks
  • Provider enablement tools such as ambient AI documentation and clinical communication platforms
  • Healthcare IT infrastructure including interoperability solutions and secure data exchange
  • Operations software for patient access, scheduling, supply chain, and care team coordination

We partner with companies addressing significant provider pain points with production-ready solutions, proven reliability, repeatable sales processes, and modern technology architecture that integrates seamlessly into complex healthcare environments.

Contact Us to Discuss Your Company →

Ethics & Responsible Innovation

We believe that with the transformative power of artificial intelligence comes the responsibility to develop and deploy it ethically. Our investment philosophy extends beyond financial returns to encompass how technology is built, who it serves, and the values that guide its use.

We partner with companies that demonstrate commitment to ethical AI development through transparent algorithms, robust data governance, patient privacy protection, and equitable access to innovation. We evaluate not just what a technology can do, but whether it should be deployed, how it impacts vulnerable populations, and whether it advances human flourishing.

Our AI Ethics Framework:

  • Transparency & Explainability – We favor companies developing interpretable AI systems where clinical decisions can be understood and validated by healthcare providers, ensuring trust and accountability in critical care decisions.
  • Privacy & Data Stewardship – We require strong data governance frameworks, patient consent protocols, de-identification practices, and security measures that exceed regulatory minimums to protect sensitive health information.
  • Bias Mitigation & Fairness – We assess how companies address algorithmic bias, ensure diverse training datasets, validate performance across different populations, and commit to equitable outcomes regardless of race, gender, or socioeconomic status.
  • Patient-Centered Design – We invest in solutions that genuinely improve patient outcomes and experiences, not just operational metrics, ensuring technology serves patients’ best interests first.
  • Regulatory Compliance & Beyond – We expect companies to meet regulatory requirements while proactively addressing emerging ethical considerations that may not yet be codified in law.
  • Beneficial Use Cases – We focus on applications that improve health outcomes, expand access to care, reduce healthcare disparities, and enhance quality of life—using technology for good, not exploitation.

This commitment to responsible innovation is embedded in our investment process, portfolio support, and long-term partnership approach. We believe the companies that will succeed in transforming healthcare are those that earn trust through ethical practices and deliver value through beneficial impact.

Contact Us to Discuss Your Company →
Linkedin-in